# The Branded Health Service Medicines (Costs) (Amendment) Regulations 2026, Regulation 2: Amendments to the Branded Health Service Medicines (Costs) Regulations 2018


(1) Regulation 3 (payment scheme) of the Branded Health Service Medicines (Costs) Regulations 2018 is amended as follows.
(2) In paragraph (1), for the table substitute the following table—
“
Table
Applicable Period
Newer presentation payment percentage
Older presentation payment percentage
1st July 2026 to the end of 2026
16.5%
11%
1st January 2027 to the end of 2027 and any subsequent calendar year
16.5%
10.9%
”.
(3) In paragraph (1AB)—
(a) for “1st July 2025 and ending at the end of 2025”, substitute “1st July 2026 and ending at the end of 2026”; and
(b) for “31.3% and not 23.4%”, substitute “8.7% and not 16.5%”.
(4) In paragraph (1AC)—
(a) for “1st July 2025 and ending at the end of 2025”, substitute “1st July 2026 and ending at the end of 2026”;
(b) in sub-paragraph (a), for “1st January 2025 and ending at the end of 30 June 2025”, substitute “1st January 2026 and ending at the end of 30 June 2026”; and
(c) in sub-paragraph (b), for “15.5%”, substitute “24.3%”.

---
Source: https://www.legislation.gov.uk/uksi/2026/614/regulation/2 (the official version)
Page: https://openlegislation.uk/branded-health-service-medicines-costs-amendment-regulations-2026/regulation-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.